How does third-party payment insurance structure distort competition and pricing in healthcare markets?
Answered at 10:03 in Healthcare Fixed: No Insurance Needed, Same Doctors, 60% Less - David Goldhill · Proven Podcast
How does third-party payment insurance structure distort competition and pricing in healthcare markets?
Third-party payers—insurance companies—control how much providers can charge and determine how many customers they receive, which fundamentally breaks the competitive pricing mechanism. Nobody in the healthcare system can make more money by lowering their prices, the opposite of every other industry. This structural design keeps prices artificially inflated and prevents the kind of natural competition that drives costs down in retail, technology, or any market where pricing power rests with individual competitors.
The core problem stems from how third-party insurance operates as a middleman. When an insurance company negotiates rates with hospitals and doctors, it sets the price ceiling—providers cannot charge more than what the insurer allows. But they also cannot gain market share by undercutting competitors, because the insurer controls which customers they serve through network design and referral patterns.
Consider how this differs from competitive markets. In retail, a store can increase profit and market share by lowering prices, attracting more customers and driving competitors out of business. A pharmaceutical company can gain market dominance through superior products at better prices. But as David Goldhill explains in the Proven Podcast episode, a hospital cannot lower its rates to win more business—the insurer still controls patient flow. This removes the primary incentive for price competition that exists everywhere else in the economy.
The result is price levels locked in place by regulatory and contractual design rather than market forces. Without the ability to compete on price, providers compete instead on ancillary services, brand reputation, or simply on consolidation—buying up smaller competitors to gain negotiating power against insurers. This consolidation itself further reduces competition rather than enhancing it, a feedback loop unique to third-party-payer systems.
"Nobody in the healthcare system can make more money, can be more profitable by lowering their prices."
David Goldhill — Founder and CEO of Sesame. A former entertainment executive who ran television operations at Universal Studios and the Game Show Network before entering healthcare as a consumer advocate and entrepreneur, Goldhill built Sesame as a direct-pay marketplace designed to restore price transparency and competitive dynamics to healthcare service delivery.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
Third-party payers—insurance companies—control how much providers can charge and determine how many customers they receive, which fundamentally breaks the competitive pricing mechanism.
David Goldhill · Healthcare Fixed: No Insurance Needed, Same Doctors, 60% Less - David Goldhill · Proven Podcast · answer at 10:03
Key takeaways
- The core problem stems from how third-party insurance operates as a middleman.
- Consider how this differs from competitive markets.
- The result is price levels locked in place by regulatory and contractual design rather than market forces.
- David Goldhill — Founder and CEO of Sesame.
Quote to remember
“Nobody in the healthcare system can make more money, can be more profitable by lowering their prices.”
— David Goldhill
The full answer · about 6 min
Third-party payers—insurance companies—control how much providers can charge and determine how many customers they receive, which fundamentally breaks the competitive pricing mechanism. Nobody in the healthcare system can make more money by lowering their prices, the opposite of every other industry. This structural design keeps prices artificially inflated and prevents the kind of natural competition that drives costs down in retail, technology, or any market where pricing power rests with individual competitors.
The core problem stems from how third-party insurance operates as a middleman. When an insurance company negotiates rates with hospitals and doctors, it sets the price ceiling—providers cannot charge more than what the insurer allows. But they also cannot gain market share by undercutting competitors, because the insurer controls which customers they serve through network design and referral patterns.
Consider how this differs from competitive markets. In retail, a store can increase profit and market share by lowering prices, attracting more customers and driving competitors out of business. A pharmaceutical company can gain market dominance through superior products at better prices. But as David Goldhill explains in the Proven Podcast episode, a hospital cannot lower its rates to win more business—the insurer still controls patient flow. This removes the primary incentive for price competition that exists everywhere else in the economy.
The result is price levels locked in place by regulatory and contractual design rather than market forces. Without the ability to compete on price, providers compete instead on ancillary services, brand reputation, or simply on consolidation—buying up smaller competitors to gain negotiating power against insurers. This consolidation itself further reduces competition rather than enhancing it, a feedback loop unique to third-party-payer systems.
"Nobody in the healthcare system can make more money, can be more profitable by lowering their prices."
David Goldhill — Founder and CEO of Sesame. A former entertainment executive who ran television operations at Universal Studios and the Game Show Network before entering healthcare as a consumer advocate and entrepreneur, Goldhill built Sesame as a direct-pay marketplace designed to restore price transparency and competitive dynamics to healthcare service delivery.
More answers from this episode
- 0:27Why does the United States healthcare system cost significantly more than other developed nations despite being 3% of the world population?
- 8:55What is the actual cost of innovation in pharmaceutical development and how does competition affect pricing once drugs are established?
- 15:03What is the lifetime cost burden for an average American employee and their family participating in the healthcare system?
- 15:37How much of healthcare spending goes directly to administrative costs of the payment system rather than actual medical care?
- 18:42How does Sesame create price transparency and competition in healthcare services compared to insurer-negotiated rates?
- 22:05What is the potential impact of artificial intelligence on healthcare access and medical practice according to healthcare innovation leaders?